Results 141 to 150 of about 70,616 (253)
A 70‐year‐old smoker with combined pulmonary fibrosis and emphysema presented with recurrent right middle lobe infections and declining pulmonary function. This case describes bronchoscopic diagnosis of endobronchial lipoma and treatment of benign obstruction in persistent middle lobe disease, highlighting the need for longer surveillance to assess ...
Anastasios Palamidas +4 more
wiley +1 more source
Clinical Course of Coronavirus disease 2019 C-19 in Patients with Bronchiectasis
OBJECTIVE: Coronavirus disease 2019 (COVID-19) has affected the whole world and caused the death of more than 6 million people. The disease has been observed to have a more severe course in patients with chronic lung diseases.
Mehmet Çoban Ağca +91 more
core +1 more source
Eosinophilic bronchial inflammation can cause severe central bronchial narrowing and recurrent atelectasis, even in patients with well‐controlled asthma. Endobronchial biopsy can establish the diagnosis and identify this potentially reversible, corticosteroid‐responsive condition.
Ryusuke Kizawa +7 more
wiley +1 more source
Characterization of bronchiectasis in lung cancer using German claims data
Bronchiectasis is a chronic pulmonary disease characterized by pathological bronchial enlargement due to various underlying etiologies, leading to symptoms such as chronic cough, sputum production, and recurrent respiratory infections.
Jeremias Götschke +8 more
doaj +1 more source
Jianmin Jin,1 Shuling Li,2 Wenling Yu,2 Xiaofang Liu,1 Yongchang Sun1,3 1Department of Respiratory and Critical Care Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, 2Department of Radiology, Beijing Tongren Hospital, Capital ...
Li S, Yu W, Liu XF, Jin J, Sun Y
core
During successful dupilumab therapy for ABPA, a new pulmonary opacity developed in an ABPA‐related bronchiectatic lesion and initially raised concern for ABPA relapse. Bronchoscopy identified Pasteurella multocida infection, allowing targeted antimicrobial treatment, continued dupilumab therapy, and eventual corticosteroid withdrawal.
Kentaro Suzuki +17 more
wiley +1 more source
Rajesh Venkitakrishnan,1 Athulya Sudheendranath,2 Anand Vijay,1 Divya Ramachandran,1 Melcy Cleetus,1 Hasha Thankam Somson,1 Susan John3 1Department of Pulmonary Medicine, Rajagiri Hospital, Aluva, Kochi, Kerala, India; 2Department of Pulmonary Medicine ...
Venkitakrishnan R +6 more
doaj
Background Microbial infection and colonization are frequently associated with disease progression and poor clinical outcomes in bronchiectasis. Identification of pathogen spectrum is crucial for precision treatment at exacerbation of bronchiectasis ...
Jie-lin Duan +7 more
doaj +1 more source
Health Science Reports, Volume 9, Issue 11, November 2026.
Oluwakemi D. Alonge +7 more
wiley +1 more source
A 68‐year‐old smoker with alcohol use presented with dyspnea, cough, and fever; imaging mimicked tuberculosis or malignancy. Empirical anti‐tubercular therapy was started for a low‐level GeneXpert signal, but biopsy confirmed pulmonary actinomycosis via pathognomonic sulfur granules of PAS‐positive filamentous organisms.
Safal Bogati +6 more
wiley +1 more source

